Efficacy and Safety of Local Intracoronary Drug Delivery in Treatment of No-Reflow Phenomenon: A Pilot Study
Author:
Affiliation:
1. Department of Cardiology; Ain Shams University Hospitals; Cairo Egypt
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference25 articles.
1. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction;Ito;Circulation,1996
2. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention;Resnic;Am Heart J,2003
3. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention;Piana;Circulation,1994
4. Myocardial no-reflow in humans;Niccoli;J Am Coll Cardiol,2009
5. Thrombus aspiration during primary percutaneous coronary intervention;Svilaas;N Engl J Med,2008
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficiency and Safety of Intracoronary Epinephrine Administration in Patients With ST-Elevation Myocardial Infarction With Refractory Coronary No-Reflow;The American Journal of Cardiology;2024-09
2. Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients;International Journal of Cardiology;2024-09
3. Intracoronary Administration of Epinephrine in the Refractory No-Reflow Phenomenon in Patients With Acute Myocardial Infarction;Kardiologiia;2024-06-30
4. Intracoronary microcatheter indwelling for continuous pumping of low-dose thrombolytic drugs: A new approach to reperfusion in acute myocardial infarction;Medicine;2024-04-05
5. The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis;Clinical Cardiology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3